Research programme: RNA interference-based therapeutics - Senetek
Latest Information Update: 16 Jul 2016
At a glance
- Originator Polish-Academy-of-Sciences
- Developer Senetek
- Class
- Mechanism of Action RNA interference
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Brain cancer; Cancer
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Brain-cancer in USA
- 16 Jul 2016 No recent reports of development identified for research development in Cancer in USA
- 15 Dec 2008 Early research in Cancer in USA (unspecified route)